Our Team

Management Team

VLADIMIR WALKO, MS, MBA
CEO and Fund Manager
  • Investment Banker with Janney Mongomery Scott
  • Private Equity Operating Partner at Credit Suisse and Arsenal Capital
  • Sr. VP Corp Dev, VP of R&D and Marketing at West Pharma
Lloyd Appel, CPA
Chief Financial Officer
  • CFO at Aisling Capital (VC)
  • CFO at New Science Ventures
  • CFO at numerous Hedge Funds
Venture Partner, MD/PHD
Open Position
Judith Marchand
Chief of Staff
  • Director, Blumberg Institute
  • Director, Hepatitis B Foundation
Joseph Zack
Director of Programs
  • GM, Advanced Tissue
  • SVP, Metabalon
  • EVP, Orasure
  • Exec Dir, ciba-geigy
Associate/Fund Analyst
Open Position

Investment Committee

TIM BLOCK, PhD

Timothy M. Block, PhD is Co-founder and former President of the Hepatitis B Foundation, its research arm, the Baruch S. Blumberg Institute, and the Pennsylvania Biotechnology Center. Dr. Block’s most significant contributions to therapeutic drug and biomarker of disease screening and discovery include methods of DNA co-transfer to mammalian cells, and methods of discovery of antiviral drugs and biomarkers of liver cancer. He has received numerous honors, including an honorary Medical Degree from the Bulgarian National Academy, elected Fellow, American Association for the Advancement of Science and of the Glycobiology Institute of the University of Oxford.  He holds 20 issued patents and 23 applications, has co-authored more than 240 scholarly papers, and was named a “Visionary in Hepatitis” by the World Hepatitis Alliance in 2017. In 2018 he was inducted as a Fellow of the National Academy of Inventors. He is also Adjunct Professor at Geisinger Commonwealth School of Medicine, and at University of Pennsylvania School of Medicine.

LOU KASSA

Louis P. Kassa III is the President of The Pennsylvania Biotechnology Center, Baruch S. Blumberg Institute, and Hepatitis B Foundation. Prior to his appointment as President, Kassa was Chief Operating Officer of PABC since December 2014. Kassa oversees daily operations at the Pennsylvania Biotech Center, which is home to the Hepatitis B Foundation and its research entity, the Baruch S. Blumberg Institute. In 2017, Kassa was promoted to Executive Vice President/Chief Operating Officer. From 2015 to 2017, Kassa worked part-time as the Chief Executive Officer for Youth Services Agency, a non-profit social services agency. He previously served as State Director and Chief Operating Officer at VisionQuest National, Ltd. Kassa has over 20 years’ experience in senior management. Kassa received his undergraduate degree from Penn State University and received a Masters in Public Administration from Villanova University in December 2007.

Scientific Advisory Board

HARVEY ALTER
  • Co-discovered Hep B virus; discovered Hep C virus.
  • Recipient of the Lasker Award and the Gairdner International Award.
Sanjay Batra
  • CEO & Founder VIAS Partners.
  • Adjunct Professor at Wake Forest Institute of Regenerative Medicine.
  • Former Johnson & Johnson Executive with 25 years of experience in start-ups.
TIMOTHY M. BLOCK
  • Founder & Former President of PA Biotech Center.
  • Faculty member at Drexel University College of Medicine and Thomas Jefferson University.
CAROL BROSGART
  • Clinical Professor, Dept of Medicine, University of California.
  • Consultant to Center for Disease Control.
NATHANIEL BROWN
  • Former CMO Presidio Pharma.
  • Former CMO Idenix Pharma.
  • Head, Glaxo Welcome/ GSK.
RAYMOND DWEK
  • Professor, Oxford University.
  • Founder Oxford Glycosciences.
  • Fellow, Royal Society, London.
TONY FORD-HUTCHINSON
  • Singulair, Vioxx and Arcoxia Research Team Lead.
  • Merck Genome Research President.
ROBERT GISH
  • Clinical Professor, Dept. Medicine, University of Nevada in Las Vegas.
  • Professor of Medicine at Stanford University.
PATRICK LAM
  • BMS group leader/co-inventor Eliquis /Apixaban.
  • Recipient of the American Chemical Society Heroes of Chemistry Award.
  • Co-discoverer of Chan-Lam Coupling Reaction.
BRUCE MARYANOFF
  • Visiting Scientist, The Scripps Research Institute.
  • Inventor of TOPAMAX.
  • Recipient of the American Chemical Society Heroes of Chemistry Award.
Richard Pestell
  • President, PA Cancer and Regenerative Medicine Center.
  • Dean of Xavier University Medical School.
  • Professor at Lankenau Institute for Medical Research.
ANAND MEHTA
  • Endowed Chair of Proteomic Biomarkers, Prof. of Cell and Molecular Pharmacology, Medical University of South Carolina.
Sicco Popma
  • CEO, IO Biosciences.
  • Former Group Head of Cell and Gene Therapy for Johnson & Johnson.
  • Former member of Dr. Carl June/ Penn research team.
KUNWAR SHAILUBHAI
  • Inventor of Trulance (plecanatide), success in translating drugs from concept through commercialization to market.
THOMAS E. SHENK
  • James A. Elkins Professor, Dept of Molecular Biology, Princeton University.
  • Founder, Evrys Bio.
MICHAEL SOFIA
  • CSO of Arbutus.
  • Discovered cure for Hep C.
  • Solvadi Research Team Lead.
  • Recipient of the Lasker Award.